Loading...

APC anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418
C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
  • N418
    C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
117309 25 µg 27€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117310 100 µg 93€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  2. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  3. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  4. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  5. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  6. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  7. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  8. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  9. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  10. Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
  11. Minute L, et al. 2020. J Immunother Cancer. 8:. PubMed
  12. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  13. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  14. Xin B, et al. 2022. Hepatology. 76:630. PubMed
  15. Huis In 't Veld LGM, et al. 2022. Cell Mol Life Sci. 79:231. PubMed
  16. Chae CS, et al. 2022. Cancer Discov. 12:1904. PubMed
  17. Minichino D, et al. 2022. J Leukoc Biol. 112:1089. PubMed
  18. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  19. Que W, et al. 2022. Sci Adv. 8:eabo4413. PubMed
  20. Liu Z, et al. 2022. Cancer Commun (Lond). 42:971. PubMed
  21. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  22. Guasconi L, et al. 2022. J Fungi (Basel). 8: . PubMed
  23. McAlpine CS, et al. 2022. J Exp Med. 219: . PubMed
  24. Zhu J, et al. 2022. Research (Wash D C). 2022:9816272. PubMed
  25. Klaus T, et al. 2022. JCI Insight. 7: . PubMed
  26. Chen Y, et al. 2023. Adv Healthc Mater. 12:e2202085. PubMed
  27. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  28. Fan R, et al. 2023. J Immunother Cancer. 11: . PubMed
  29. Taniguchi S, et al. 2023. Nat Commun. 14:143. PubMed
  30. Wang D, et al. 2023. J Exp Clin Cancer Res. 42:26. PubMed
  31. Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed
  32. Duan H, et al. 2022. Adv Sci (Weinh). 9:e2103719. PubMed
  33. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  34. Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed
  35. Sauter M, et al. 2022. STAR Protoc. 3:101664. PubMed
  36. Sia ZR, et al. 2022. J Virol. 96:e0100622. PubMed
  37. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  38. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  39. Shi X, et al. 2023. iScience. 26:106143. PubMed
  40. Pasqual G, et al. 2023. Methods Mol Biol. 2618:71. PubMed
  41. Zhang X, et al. 2023. Front Immunol. 14:1116749. PubMed
  42. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  43. Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed
  44. Bhaskar A, et al. 2023. iScience. 26:106644. PubMed
  45. Wang D, et al. 2023. Nat Commun. 14:2943. PubMed
  46. Song J, et al. 2023. iScience. 26:106753. PubMed
  47. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  48. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  49. Gujar R, et al. 2016. J Immunol. 197: 1650 - 1662. PubMed
  50. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  51. Riva A, et al. 2013. J Immunol. 190:5961. PubMed
  52. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  53. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  54. Page N, et al. 2018. Immunity. 48:937. PubMed
  55. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  56. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  57. Kitai H, et al. 2022. BMC Biol. 20:248. PubMed
  58. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  59. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  60. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  61. Jiang Q, et al. 2022. Theranostics. 12:59. PubMed
  62. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
  63. Meng W, et al. 2021. JCI Insight. 6:. PubMed
  64. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  65. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  66. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  67. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  68. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  69. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  70. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  71. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  72. Sauter M, et al. 2022. iScience. 25:103677. PubMed
  73. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  74. Nam J, et al. 2021. Adv Sci (Weinh). 2002577:8. PubMed
  75. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  76. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  77. Wegmann F, et al. 2015. Clin Vaccine Immunol. 22: 1004-1012. PubMed
  78. Qian F, et al. 2015. J Mol Cell Biol. . PubMed
  79. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  80. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  81. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  82. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  83. Shin M et al. 2019. Cell Chem Biol. 26(7):1036-1041 . PubMed
  84. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  85. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  86. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  87. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  88. Liang W, et al. 2022. Methods Mol Biol. 2574:221. PubMed
  89. Wiernicki B, et al. 2022. Nat Commun. 13:3676. PubMed
  90. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  91. Chen WS, et al. 2021. Cell Rep. 37:109974. PubMed
  92. Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed
  93. Prado C, et al. 2012. J Immunol. 188:3062. PubMed
  94. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  95. Bode K, et al. 2020. Cell Reports. 29(13):4435-4446.e9.. PubMed
  96. Wiede F, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  97. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  98. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  99. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  100. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  101. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  102. O'Shea NR, Chew TS 2016. J Crohns Colitis. 10(12):1417-1427. PubMed
  103. Angelidis I, et al. 2019. Nat Commun. 10:963. PubMed
  104. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  105. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  106. Sharma PK, et al. 2018. Cancer Gene Ther. 25:27. PubMed
  107. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  108. Hao F, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  109. Kulkarni NN, et al. 2021. J Biol Chem. 297:100828. PubMed
  110. Dos Santos Dias L, et al. 2021. PLoS Pathog. e1009324:17. PubMed
  111. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  112. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  113. Lin SY, et al. 2017. Autophagy. 14:778. PubMed
  114. Yuan B, et al. 2021. J Immunother Cancer. 9:. PubMed
  115. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  116. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  117. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  118. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  119. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  120. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  121. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  122. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  123. Bunn P, et al. 2014. J Immunol. 192:3709. PubMed
  124. Ustarroz-Cano M, et al. 2012. J Immunotoxicol. 9:374. PubMed
  125. Bak S, et al. 2008. Mol Immunol. 45:1414. PubMed
  126. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  127. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  128. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  129. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  130. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  131. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  132. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  133. McAlpine CS, et al. 2021. Nature. 595:701. PubMed
  134. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  135. Dokoshi T, et al. 2021. J Clin Invest. 131:. PubMed
  136. Glauser D, et al. 2013. J Virol. 87:10828. PubMed
  137. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  138. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  139. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  140. Li N, et al. 2021. eLife. 10:00. PubMed
  141. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  142. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  143. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  144. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  145. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  146. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  147. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  148. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  149. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
  150. Li W, et al. 2021. Front Pharmacol. 12:697483. PubMed
  151. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  152. Liu M, et al. 2016. PLoS One. 11:e0166165. PubMed
  153. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  154. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  155. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  156. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
  157. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  158. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  159. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  160. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  161. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  162. Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed
  163. Xu M, et al. 2022. Genes Dis. 9:429. PubMed
  164. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  165. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  166. White C, et al. 2015. J Immunol. 194:697. PubMed
  167. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  168. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  169. Liu Z, et al. 2021. Immunity. 54(2):247-258.e7. PubMed
  170. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  171. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  172. Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed
  173. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  174. He J, et al. 2019. J Clin Invest. 130. PubMed
  175. Kemp V, et al. 2018. Cancer Gene Ther. 26:268. PubMed
  176. Kramer K, et al. 2017. ACS Omega. 0.240972222. PubMed
  177. Liu W, et al. 2019. Epigenetics. 1.192361111. PubMed
  178. Marsh L, et al. 2009. Am J Physiol Lung Cell Mol Physiol. 296:L442. PubMed
  179. Yang Y, et al. 2021. Sci Adv. 7:eabf6290. PubMed
  180. Kim S, et al. 2021. Elife. 10:. PubMed
  181. Covarrubias AJ, et al. 2020. Nat Metab. 1265:2. PubMed
  182. Li C, et al. 2021. Cell Metabolism. 33(8):1610-1623.e5. PubMed
  183. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  184. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  185. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  186. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  187. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  188. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  189. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  190. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  191. Lang V, et al. 2021. Elife. 10:. PubMed
  192. Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
  193. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  194. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  195. Ye Y, et al. 2017. Sci Immunol. 2:17. PubMed
  196. Zeng J, et al. 2018. J Immunol. 200:3407. PubMed
  197. Trinh HKT, et al. 2019. J Cell Mol Med. 23:3441. PubMed
  198. Fischer FA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  199. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  200. Tukaramrao DB, et al. 2021. Cancers (Basel). 13:. PubMed
  201. Wüthrich M, et al. 2021. MBio. 12:e0201821. PubMed
  202. Schneider KM, et al. 2022. Nat Commun. 13:3964. PubMed
  203. Kohn EM, et al. 2022. J Immunol. 208:1417. PubMed
  204. Wang Y, et al. 2022. J Control Release. 349:118. PubMed
  205. Shan B, et al. 2020. Nat Metab. 1332:2. PubMed
  206. Zhao L, et al. 2021. STAR Protocols. 2:100732. PubMed
  207. Peng X, et al. 2016. J Cell Sci. 129: 1831 - 1842. PubMed
  208. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  209. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  210. Chitu V, et al. 2020. Cell Reports. 30(9):3004-3019. PubMed
  211. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  212. Yamada S, et al. 2018. Arterioscler Thromb Vasc Biol. 38:994. PubMed
  213. Chu LH, et al. 2018. Nat Commun. 9:996. PubMed
  214. Tang Z, et al. 2021. Stem Cell Res Ther. 12:397. PubMed
  215. Zhang XW, et al. 2021. Oncoimmunology. 10:1920739. PubMed
  216. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  217. Berthold N, et al. 2013. Antimicrob Agents Chemother. 57:402. PubMed
  218. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  219. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  220. Li C, et al. 2018. Cell. 174:285. PubMed
  221. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  222. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  223. Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
  224. Woodring T, et al. 2022. iScience. 25:104934. PubMed
  225. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  226. Zhao W, et al. 2014. Clin Vaccine Immunol. 21:74. PubMed
  227. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  228. Qian Z, et al. 2022. Biomedicines. 10:. PubMed
  229. Bezu L, et al. 2022. J Immunother Cancer. 10:. PubMed
  230. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  231. Vogel A, et al. 2022. Cell Rep. 38:110420. PubMed
  232. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  233. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  234. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  235. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  236. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  237. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  238. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  239. Wang S, et al. 2020. J Cell Mol Med. 24:722. PubMed
  240. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  241. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  242. Jiang Y, et al. 2021. Nat Commun. 12:742. PubMed
  243. Lisk C, et al. 2021. Front Immunol. 12:624197. PubMed
  244. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  245. Takahashi N, et al. 2022. Tohoku J Exp Med. 257:171. PubMed
  246. Grube J, et al. 2022. Cell Death Dis. 13:704. PubMed
  247. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
  248. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  249. Ryu S, et al. 2021. eLife. 0.416666666666667. PubMed
  250. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  251. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  252. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  253. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  254. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  255. Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed
  256. Wang C, et al. 2018. Sci Transl Med. 10. PubMed
  257. Dye BR, et al. 2020. Biomaterials. 234:119757. PubMed
  258. Shen H, et al. 2022. Nat Commun. 13:5013. PubMed
  259. Smith LK, et al. 2021. Elife. 10:. PubMed
  260. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  261. Li H, et al. 2022. iScience. 25:104481. PubMed
  262. Xiao Z, et al. 2022. Mater Today Bio. 15:100297. PubMed
  263. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  264. Nicholls J, et al. 2021. Front Cell Dev Biol. 9:737880. PubMed
  265. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  266. Gentschev I, et al. 2012. PLoS One. 7:e37239. PubMed
  267. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
  268. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  269. Matisz CE, et al. 2018. Am J Pathol. 188:2589. PubMed
  270. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  271. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  272. Zhang B, et al. 2021. Nature. 599:471. PubMed
  273. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  274. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  275. Gawish R, et al. 2022. Elife. 11:. PubMed
  276. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  277. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  278. Morrissey MA, et al. 2018. Elife. 7:e36688. PubMed
  279. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  280. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  281. Yu L, et al. 2022. Front Immunol. 13:937331. PubMed
  282. Sethuraman SN, et al. 2020. Theranostics. 10:3397. PubMed
  283. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  284. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  285. Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
  286. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  287. Rana MN, et al. 2021. Front Pharmacol. 12:643215. PubMed
RRID
AB_313778 (BioLegend Cat. No. 117309)
AB_313779 (BioLegend Cat. No. 117310)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD11c
Specificity Alt (DOES NOT SHOW ON TDS):
CD11c
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD11c on UniProt.org

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Spark Blue™ 515 anti-mouse CD11c N418 FC
PerCP/Fire™ 806 anti-mouse CD11c N418 FC
Spark PLUS UV™ 395 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account